Propanc Biopharma, Inc.
PPCBHealthcare|Biotechnology|AU
$1.77
+0.13 (+7.93%)
DCF Value
$3.50
Tangible Book / Share
$83.67
Cash / Share
$7.40
Ownership Breakdown
66.9%
Float
1.0M
Shares Outstanding
0.7M
Float Shares
Insider Trades (24)
Last 4 quarters: 264,561,820 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| ZELINGER JOSEF | director | Jul 5, 2023 | AWARD | 15,000,000 | $0.01 | $150.0K | Form 4 |
| Kenyon Julian Norman | director, officer: Chief Scientific Officer | Aug 17, 2021 | AWARD | 3,420,000 | — | — | Form 4 |
| Nathanielsz James Andrew | director, officer: CEO/CFO | Aug 17, 2021 | AWARD | 5,928,000 | — | — | Form 4 |
| Nathanielsz James Andrew | director, officer: CEO/CFO | Aug 17, 2021 | AWARD | 2,800,000 | — | — | Form 4 |
| ZELINGER JOSEF | director | Aug 17, 2021 | DISPOSED | 0 | — | — | Form 4 |
| Campiciano Carlo M | officer | Jun 24, 2019 | OTHER | 0 | — | — | Form 4 |
| Kenyon Julian Norman | director, officer: Chief Scientific Officer | May 14, 2019 | AWARD | 9,750,000 | $0.01 | $82.9K | Form 4 |
| Kenyon Julian Norman | director, officer: Chief Scientific Officer | May 14, 2019 | AWARD | 9,750,000 | — | — | Form 4 |
| Nathanielsz James Andrew | director, officer: CEO, Acting CFO, Chairman | May 14, 2019 | AWARD | 19,500,000 | $0.01 | $183.3K | Form 4 |
| Nathanielsz James Andrew | director, officer: CEO, Acting CFO, Chairman | May 14, 2019 | AWARD | 19,500,000 | — | — | Form 4 |
| Nathanielsz James Andrew | director, officer: CEO, CFO, Secretary, Treasurer | Apr 14, 2016 | AWARD | 71,500,000 | $0.03 | $2.1M | Form 4 |
| Nathanielsz James Andrew | director, officer: CEO, CFO, Secretary, Treasurer | Feb 4, 2015 | J | 33,259,350 | $33259.00 | $1106.17B | Form 4 |
| Kenyon Julian Norman | director | Apr 14, 2016 | AWARD | 71,500,000 | $0.03 | $2.1M | Form 4 |
| Kenyon Julian Norman | director | Feb 4, 2015 | J | 17,654,470 | $17654.00 | $311.67B | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Sep 4, 2012 | SELL | 250,000 | $0.20 | $50.0K | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Sep 14, 2012 | SELL | 5,000 | $0.20 | $1.0K | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Dec 13, 2012 | SELL | 5,500 | $0.20 | $1.1K | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Jan 23, 2013 | SELL | 15,000 | $0.20 | $3.0K | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Jul 5, 2013 | SELL | 55,000 | $0.09 | $5.0K | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Nov 9, 2014 | AWARD | 500,000 | — | — | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Aug 23, 2012 | BUY | 250,000 | $0.20 | $50.0K | Form 4 |
| Kenyon Julian Norman | director, 10 percent owner: | Jul 16, 2012 | DISPOSED | 0 | — | — | Form 4 |
| Kenyon Julian Norman | director, 10 percent owner: | Jul 16, 2012 | DISPOSED | 0 | — | — | Form 4 |
| Nathanielsz James Andrew | director, 10 percent owner, officer: Chief Executive Officer | Dec 16, 2011 | OTHER | 0 | — | — | Form 4 |